US 7,531,320 B2
Modulation of β-catenin/TCF-activated transcription
Michael Kahn, Kirkland, Wash. (US); SeWoong Oh, Suwon (Korea, Republic of); DaeHoon Kim, Suwon (Korea, Republic of); JongRyul Ha, Suwon (Korea, Republic of); and Katayoon Hojjati-Emami, Seattle, Wash. (US)
Assigned to Choongwae Pharma Corporation, Seoul (Korea, Republic of)
Filed on Aug. 27, 2004, as Appl. No. 10/928,626.
Claims priority of provisional application 60/498451, filed on Aug. 28, 2003.
Prior Publication US 2005/0059628 A1, Mar. 17, 2005
Int. Cl. C12P 21/06 (2006.01)
U.S. Cl. 435—69.1 22 Claims
 
1. A method for increasing the expression of a target gene induced by β-catenin, comprising contacting a stem cell with an agent having the structure of formula (I),

OG Complex Work Unit Drawing
wherein A is —(CHR3)— or —(C═O)—, B is —(CHR4)— or —(C═O)—, D is —(CHR5)— or —(C═O)—, E is -(ZR6)— or —(C═O)—, G is —(XR7)n—, —(CHR7)—(NR8)—, —(C═O)—(XR9)—, or —(C═O)—, W is —Y(C═O)—, —(C═O)NH—, —(SO2)— or nothing, Y is oxygen or sulfur, X and Z is independently nitrogen or CH, n=0 or 1; and R1, R2, R3, R4, R5, R6, R7, R8 and R9 are each independently selected from an amino acid side chain moiety, a derivative of an amino acid side chain moiety, and stereoisomers thereof, and
wherein the agent is contacted with the stem cell in an amount effective to increase the expression of a target gene induced by β-catenin.